PPD managed a net revenue of $313.1m (€250m) for the third quarter
of 2006, an increase of 14.6 per cent over net revenue of $273.3m
for the third quarter of 2005. This has been buoyed on by the
strong performance by the company's...
As it steps up its presence in the major clinical trials
recruitment hubs in Asia, Quintiles has announced its intention to
open a central lab in India to help feed its expanding network of
clinical trial operations in the country.
Paraxel has acquired a $65m (€52m) US business that will inflate
its early phase capacity enough to make it one of the largest
providers of Phase I services in the world and help "return its US
operations to profitability".
Falling foul of the patient recruitment problems that are plaguing
the industry, RegeneRx Biopharmaceuticals has recruited an
undisclosed contract research organisation (CRO) to help it with
the mountainous task.
After opening its first large scale clinical research facility
earlier this year in the US through its new clinical research
division, Qualia Clinical Service, Holmes Biopharma is starting to
see the business gain momentum.
GTC Biotherapeutics and LFB Biotechnologies have entered into a
collaboration, which focuses on recombinant plasma proteins and
monoclonal antibodies (mAbs) to eventually develop a robust
pipeline for treating conditions such as haemophilia.
A new firm called Clinical Conduct Associates has been launched in
Ireland in the hope of attracting new clinical research business to
this "underutilised region" from pharmaceutical companies
Mobious Genomics has announced a prototype version of a new
immunoassay that identified a low concentration bacterial sample
within 40 seconds, vastly improving on the six - forty eight hours
it currently takes to identify the same...